# Efficacy and Safety of Factor VIIa on Rebleeding After Surgery for Spontaneous Intracerebral Hemorrhage (ICH)

> **NCT00128050** · PHASE2 · COMPLETED · sponsor: **Fondazione IRCCS Policlinico San Matteo di Pavia** · enrollment: 30 (actual)

## Conditions studied

- Intracerebral Hemorrhage

## Interventions

- **DRUG:** rFactor VIIa (Eptacog alfa, NovoNordisk)
- **DRUG:** rFVIIa
- **OTHER:** Sodiun chloride 0.9%

## Key facts

- **NCT ID:** NCT00128050
- **Lead sponsor:** Fondazione IRCCS Policlinico San Matteo di Pavia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2009-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00128050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00128050, "Efficacy and Safety of Factor VIIa on Rebleeding After Surgery for Spontaneous Intracerebral Hemorrhage (ICH)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00128050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*